-
A recently published University of Washington study found prescription opioid companies competing with Purdue, the maker of OxyContin, increased marketing efforts after a 2007 Kentucky lawsuit.
-
A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia. The cases are pressing ahead even as companies have been settling many of the claims filed by state and local governments across the U.S.
-
Doctors were more likely to choose generic drugs over pricier brand names when teaching hospitals limited access by pharmaceutical sales representatives, a study finds.
-
An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer, an analysis by Kaiser Health News reveals.
-
Months after a man died in a botched clinical trial in France, the company that ran it has opened a big research facility in New Jersey, where as many as 50 clinical trials could be done each year.
-
Repeated extensions of drug patents help fend off competitors, researchers say, keeping prices high. And the fact that Medicare and Medicaid can't negotiate for discounts doesn't help, either.
-
Hundreds of pharmaceutical and medical device firms have paid doctors for their services even after the doctors were disciplined for serious misconduct by state medical boards, an analysis finds.
-
Researchers say the time doctors spend with drug company representatives when they are dropping off meals is probably more important than the food in influencing prescription choices.
-
President Obama calls the controversial practice "one of the most insidious tax loopholes out there." Now the Treasury Department has introduced rules aimed at reducing the incentives for inversions.